# Medical Device Development Plan Template

## Executive Summary
This template provides a comprehensive framework for medical device development projects aligned with FDA QSR and ISO 13485 requirements.

## Project Overview
**Device Classification:** [Class I/II/III]
**Regulatory Pathway:** [510(k)/PMA/De Novo]
**Target Market:** [US/EU/Global]
**Development Timeline:** [Estimated duration]

## Development Phases

### Phase 1: Concept and Feasibility (Months 1-6)
#### Activities
- [ ] Market research and competitive analysis
- [ ] Clinical need assessment
- [ ] Regulatory pathway determination
- [ ] Initial risk analysis
- [ ] Proof of concept development

#### Deliverables
- Market analysis report
- Product requirements document
- Regulatory strategy document
- Initial risk management file
- Feasibility study results

### Phase 2: Design and Development (Months 7-18)
#### Activities
- [ ] Design controls implementation
- [ ] Design inputs definition
- [ ] Design outputs specification
- [ ] Verification and validation planning
- [ ] Risk management process execution

#### Deliverables
- Design history file (DHF)
- Design controls procedures
- V&V protocols and reports
- Risk management file updates
- Usability engineering file

### Phase 3: Clinical Evaluation (Months 19-30)
#### Activities
- [ ] Clinical investigation plan development
- [ ] IRB/Ethics committee approval
- [ ] Clinical data collection
- [ ] Clinical evaluation report preparation
- [ ] Post-market clinical follow-up planning

#### Deliverables
- Clinical investigation plan
- Clinical study report
- Clinical evaluation report
- Post-market surveillance plan

### Phase 4: Regulatory Submission (Months 31-36)
#### Activities
- [ ] Regulatory submission preparation
- [ ] Quality system documentation
- [ ] Manufacturing process validation
- [ ] Labeling development
- [ ] FDA/Notified Body interaction

#### Deliverables
- 510(k) submission or PMA
- Quality manual
- Manufacturing procedures
- Labeling and IFU
- Regulatory correspondence

### Phase 5: Manufacturing and Launch (Months 37-42)
#### Activities
- [ ] Manufacturing scale-up
- [ ] Quality system implementation
- [ ] Supply chain establishment
- [ ] Commercial launch preparation
- [ ] Post-market surveillance initiation

#### Deliverables
- Manufacturing procedures
- Quality system records
- Commercial launch plan
- Post-market surveillance system

## Risk Management Integration
- Risk management file maintenance throughout development
- Regular risk assessments at each phase gate
- Clinical risk-benefit analysis
- Post-market risk monitoring

## Quality System Requirements
- Design controls per 21 CFR 820.30
- ISO 13485 compliance
- Risk management per ISO 14971
- Usability engineering per IEC 62366

## Regulatory Milestones
- Pre-submission meetings (if applicable)
- IDE approval (if required)
- Regulatory submission
- FDA clearance/approval
- International registrations

---
Related Resources:
- [Regulatory Compliance](../regulatory-compliance/)
- [Quality Management](../quality-management/)
- [Clinical Research](../clinical-research/)
